THE COMBINATION CONUNDRUM: COMPARING REIMBURSEMENT OUTCOMES FOR ONCOLOGY COMBINATION PRODUCTS IN THE UK AND FRANCE

被引：0
|
作者：
Tzaras, D.
Moran, V
机构：
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA306
引用
收藏
页码：S379 / S380
页数：2
相关论文
共 50 条
  • [1] ONCOLOGY COMBINATION MARKET ACCESS CONUNDRUM IN EUROPE
    Mycka, J.
    Dalal, N.
    Dellamano, R.
    Pereira, E.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S285 - S285
  • [2] DO COMPLEXITIES OF COMBINATION ONCOLOGY SUBMISSIONS IMPACT REIMBURSEMENT OUTCOMES: AN EVALUATION OF MULTI-THERAPY ONCOLOGY REGIMENS IN CANADA
    Liovas, A.
    Privolnev, Y.
    Pan, V
    Jakac-Sinclair, N.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S266 - S266
  • [3] ANALYSIS OF REIMBURSEMENT OUTCOMES FOR ORPHAN DRUGS WITH EMA EXCEPTIONAL CIRCUMSTANCES DESIGNATION IN FRANCE, GERMANY, AND THE UK
    Lach, K.
    Pisarczyk, K.
    Beckerman, R.
    Meletiche, D.
    [J]. VALUE IN HEALTH, 2020, 23 : S757 - S757
  • [4] COMBINATION ONCOLOGY THERAPIES IN THE EU5: NAVIGATING THE ROAD TO REIMBURSEMENT AND OPTIMIZING UPTAKE IN MALIGNANT MELANOMA
    Privolnev, Y.
    Cox, J.
    Webster, R.
    [J]. VALUE IN HEALTH, 2018, 21 : S54 - S54
  • [5] Characteristics and outcomes of new molecular oncology drug approvals, in combination or monotherapy
    Ranganathan, Sruthi
    Haslam, Alyson
    Tuia, Jordan
    Prasad, Vinay
    [J]. JOURNAL OF CANCER POLICY, 2024, 39
  • [6] DO MANUFACTURERS STILL SEE VALUE IN SUBMITTING EVIDENCE FOR A NICE APPRAISAL IN ENGLAND? COMPARING AND CONTRASTING TERMINATED APPRAISALS BETWEEN ONCOLOGY AND NON-ONCOLOGY AND MONOTHERAPIES AND COMBINATION PRODUCTS
    Chirico, G.
    Lorquet, H.
    Craddy, P.
    Foxon, G.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S309 - S309
  • [7] Comparing outcomes of exenatide/insulin and exenatide/oral anti-hyperglycaemic combination therapies
    Shankland, R.
    Oelbaum, R.
    Simmonds, J.
    Allen, A.
    [J]. DIABETIC MEDICINE, 2014, 31 : 119 - 119
  • [8] Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy
    Weber, Michael A.
    Julius, Stevo
    Kjeldsen, Sverre E.
    Jia, Yan
    Brunner, Hans R.
    Zappe, Dion H.
    Hua, Tsushung A.
    McInnes, Gordon T.
    Schork, Anthony
    Mancia, Giuseppe
    Zanchetti, Alberto
    [J]. JOURNAL OF HYPERTENSION, 2012, 30 (11) : 2213 - 2222
  • [9] Kahook Dual Blade versus Trabectome (KVT): Comparing Outcomes in Combination with Cataract Surgery
    Fliney, Greg D.
    Kim, Eliott
    Sarwana, Miriam
    Wong, Sze
    Tai, Tak Yee Tania
    Liu, Ji
    Sarrafpour, Soshian
    Chadha, Nisha
    Teng, Christopher C.
    [J]. CLINICAL OPHTHALMOLOGY, 2023, 17 : 145 - 154
  • [10] REIMBURSEMENT OUTCOMES FOR COMBINATION THERAPIES VS MONOTHERAPIES IN LUNG CANCER AND MULTIPLE MYELOMA IN THE TOP FIVE EUROPEAN MARKETS
    Izmirlieva, M. A.
    Reinaud, F.
    Taiyeb, M.
    Ando, G.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S7 - S7
12345